USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
University Medical Associates
Address:
530 S Jackson Street
Louisville, KY 40202
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $218,949.00 4
SBIR Phase II $1,011,857.00 3

Award List:

ARTIFICIAL KIDNEY MEMBRANES OF IMPROVED BIOCOMPATIBILITY

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Richard A Ward , Principal Investigator
Abstract:
N/a

PEPTIDES FROM WHEY PROTEIN FOR PERITONEAL DIALYSIS

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$48,000.00
Agency:
HHS
Principal Investigator:
Elias Klein , Principal Investigator
Abstract:
N/a

ARTIFICIAL KIDNEY MEMBRANES OF IMPROVED BIOCOMPATIBILITY

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$283,000.00
Agency:
HHS
Principal Investigator:
Richard A Ward , Principal Investigator
Abstract:
Hemodialysis is widely used to sustain life in individuals who have lost kidney function. the membrane material most commonly used for this purpose is regenerated cellulose. however, regenerated cellulose is not inert; it stimulates the coagulation and complement systems and may be a cause ofboth… More

PEPTIDES FROM WHEY PROTEIN FOR PERITONEAL DIALYSIS

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Elias Klein , Principal Investigator
Abstract:
Peritoneal dialysate used in treating patients with end- stage renal disease utilizes the osmotic force of high concentrations of glucose to transfer water from the body pool to the dialysate. this procedure has been identified as a source of several metabolic problems in such patients, especially… More

ELISA KIT SPECIFIC FOR THE ANTI-PHOSPHOLIPID SYNDROME

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

ELISA KIT SPECIFIC FOR THE ANTI-PHOSPHOLIPID SYNDROME

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$228,857.00
Agency:
HHS
Principal Investigator:
Abstract:
In some patients, phospholipid-binding antibodies have been associated with recurrent venous and/or arterial thrombosis as well as with recurrent fetal loss (the antiphospholipid syndrome, or aps). these antibodies are induced in a variety of clinical circumstances, and it is likely that the above… More

Reduction of B 2 Microglobulin in Hemodialysis Patients

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$71,949.00
Agency:
HHS
Principal Investigator:
Elias Klein
Abstract:
More than 100,000 patients now receive chronic hemodialysis therapy in Medicare's End StageRenal Disease Program. Hemodialysis related amyloidosis affects a significant portion of these patients.The syndrome presents clinically as carped tunnel syndrome, cystic bone lesions, and arthropathies.… More